1. Home
  2. PLBC vs PRTC Comparison

PLBC vs PRTC Comparison

Compare PLBC & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plumas Bancorp

PLBC

Plumas Bancorp

HOLD

Current Price

$50.46

Market Cap

340.7M

Sector

Finance

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$17.11

Market Cap

400.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBC
PRTC
Founded
1980
2015
Country
United States
United States
Employees
N/A
90
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.7M
400.2M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
PLBC
PRTC
Price
$50.46
$17.11
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$57.67
N/A
AVG Volume (30 Days)
52.8K
6.7K
Earning Date
04-15-2026
04-29-2026
Dividend Yield
2.60%
N/A
EPS Growth
N/A
N/A
EPS
4.54
N/A
Revenue
N/A
N/A
Revenue This Year
$25.59
N/A
Revenue Next Year
$5.15
N/A
P/E Ratio
$11.28
$8.09
Revenue Growth
N/A
N/A
52 Week Low
$39.70
$14.50
52 Week High
$54.58
$19.92

Technical Indicators

Market Signals
Indicator
PLBC
PRTC
Relative Strength Index (RSI) 46.14 48.92
Support Level $40.58 $16.51
Resistance Level $52.61 $18.34
Average True Range (ATR) 1.30 0.63
MACD -0.17 -0.05
Stochastic Oscillator 6.49 6.72

Price Performance

Historical Comparison
PLBC
PRTC

About PLBC Plumas Bancorp

Plumas Bancorp provides banking products and services in Northeastern California and Northwestern Nevada, offering a range of deposit products for commercial and retail customers, including checking, savings, money market accounts, time deposits, retirement accounts, and sweep accounts for businesses and public entities, along with digital banking services such as mobile and internet banking, remote deposit, and electronic funds transfers, as well as other customary banking services. Its loan portfolio comprises commercial real estate, commercial and industrial, consumer, agricultural, residential real estate, and construction and land development loans, and the company generates its revenue from loans and investment securities, with additional income from service fees.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: